4basebio (4BB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 1,000.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 1,550.00
  • 52 Week Low: 985.00
  • Currency: UK Pounds
  • Shares Issued: 15.51m
  • Volume: 816
  • Market Cap: £155.09m

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
86.39% above the market average86.39% above the market average86.39% above the market average86.39% above the market average86.39% above the market average
48.39% above the sector average48.39% above the sector average48.39% above the sector average48.39% above the sector average48.39% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
93.36% above the market average93.36% above the market average93.36% above the market average93.36% above the market average93.36% above the market average
84.00% above the sector average84.00% above the sector average84.00% above the sector average84.00% above the sector average84.00% above the sector average
Price Book Ratio
83.87% below the market average83.87% below the market average83.87% below the market average83.87% below the market average83.87% below the market average
43.59% below the sector average43.59% below the sector average43.59% below the sector average43.59% below the sector average43.59% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
64.31% below the market average64.31% below the market average64.31% below the market average64.31% below the market average64.31% below the market average
26.09% below the sector average26.09% below the sector average26.09% below the sector average26.09% below the sector average26.09% below the sector average
Price Chg 3m
81.49% below the market average81.49% below the market average81.49% below the market average81.49% below the market average81.49% below the market average
69.57% below the sector average69.57% below the sector average69.57% below the sector average69.57% below the sector average69.57% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
74.1% below the market average74.1% below the market average74.1% below the market average74.1% below the market average74.1% below the market average
85.71% below the sector average85.71% below the sector average85.71% below the sector average85.71% below the sector average85.71% below the sector average
Momentum 20
64.68% above the market average64.68% above the market average64.68% above the market average64.68% above the market average64.68% above the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
93.91% below the market average93.91% below the market average93.91% below the market average93.91% below the market average93.91% below the market average
75% below the sector average75% below the sector average75% below the sector average75% below the sector average75% below the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
54.41% below the market average54.41% below the market average54.41% below the market average54.41% below the market average54.41% below the market average
8.7% below the sector average8.7% below the sector average8.7% below the sector average8.7% below the sector average8.7% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
81.96% below the market average81.96% below the market average81.96% below the market average81.96% below the market average81.96% below the market average
56.25% below the sector average56.25% below the sector average56.25% below the sector average56.25% below the sector average56.25% below the sector average
Operating Profit Loss
85.06% below the market average85.06% below the market average85.06% below the market average85.06% below the market average85.06% below the market average
52.17% below the sector average52.17% below the sector average52.17% below the sector average52.17% below the sector average52.17% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
8.65% above the market average8.65% above the market average8.65% above the market average8.65% above the market average8.65% above the market average
30.23% above the sector average30.23% above the sector average30.23% above the sector average30.23% above the sector average30.23% above the sector average
Cash
46.43% above the market average46.43% above the market average46.43% above the market average46.43% above the market average46.43% above the market average
55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
17.91% above the market average17.91% above the market average17.91% above the market average17.91% above the market average17.91% above the market average
27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average
Buys 1y
70.59% above the market average70.59% above the market average70.59% above the market average70.59% above the market average70.59% above the market average
56.25% above the sector average56.25% above the sector average56.25% above the sector average56.25% above the sector average56.25% above the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

4basebio Market Data

Currency UK Pounds
Share Price 1,000.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 1,550.00
52 Week Low 985.00
Volume 816
Shares Issued 15.51m
Market Cap £155.09m

4basebio Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
66.02% below the market average66.02% below the market average66.02% below the market average66.02% below the market average66.02% below the market average
4.35% below the sector average4.35% below the sector average4.35% below the sector average4.35% below the sector average4.35% below the sector average
Price Trend
29% below the market average29% below the market average29% below the market average29% below the market average29% below the market average
4.35% above the sector average4.35% above the sector average4.35% above the sector average4.35% above the sector average4.35% above the sector average
Income Not Available
Growth
58.62% above the market average58.62% above the market average58.62% above the market average58.62% above the market average58.62% above the market average
68.75% above the sector average68.75% above the sector average68.75% above the sector average68.75% above the sector average68.75% above the sector average

4basebio Dividends

No dividends found

Trades for 11-Jul-2025

Time Volume / Share Price
15:44 400 @ 1,005.00p
14:39 400 @ 1,005.00p
11:50 4 @ 1,039.20p
11:46 12 @ 1,005.00p

4basebio Key Personnel

CEO Heikki Lanckriet
CFO David John Roth

Top of Page